Skip to main content
  • EN
  • FI
  • SV
Login

Main navigation

  • About FinnGen
    • Summary & Goals
      • Goals
      • FinnGen 1-2
      • FinnGen 3 (2023-2027)
    • Consortium
      • Partners
      • Funding
      • Governance
      • Steering Committee Members
      • Scientific Committee Members
      • Teams
      • Collaboration
    • Impact
      • National Impact
      • National Research Network
      • Open Science
      • Research Highlights
    • Why Finland?
      • Biobank Network
      • Legislative Review
      • National Registries
      • Population Genetic History
      • Industry partners
    • Mediabank
  • For Researchers
    • Research Activities
      • Core Analyses
      • Disease Task Forces
      • Expansion Areas
      • Global Initiatives
    • Cohort and Data
      • Register Data
      • Basic Characteristics
      • Clinical Endpoints
      • Genetic Data
      • Laboratory Values
      • Other Phenotype Data
      • Recruitment
      • Other Biological Data
      • Data Available
    • Accessing Data, Results & Tools
      • Access results
      • Computing environment
      • How We Collaborate
      • Partner researchers
      • Public data releases
      • Tools
    • Publications
    • Researcher FAQ
  • For Participants
    • Participation
      • Study Participants
      • Biobanks' Role in FinnGen
      • Biobank Contact Information
      • Recall Studies
      • Questions and answers
    • Data Protection and Security
      • Data Protection
      • Data Security
      • Sample & Data Flow
      • Data Protection Statement
    • Significance
      • Videos
  • News
  • EN
  • FI
  • SV

Links

  • PheWeb
  • Risteys
  • Meta-analysis Pheweb (FG-MVP-UKBB)
  • FinnGen handbook
  • Meta-analysis Pheweb (FG-UKBB)
  • Coding variant browser
  • Endpoint Browser
  • FinnGen GITHUB
  • LAVAA volcano plot
  • Multiple Manhattan Plot
  • Variant Cluster Corrector
  • Variant Cluster Call Corrector
Breadcrumb
  1. Home

The risk stratification and predictive performance of a new combined polygenic risk score for hepatocellular carcinoma

Submitted by Frida Mäkelä on Mon, 08/12/2024 - 10:10
  • Read more about The risk stratification and predictive performance of a new combined polygenic risk score for hepatocellular carcinoma

Causal relationship analysis between 35 blood/urine metabolites and gastroesophageal reflux disease: A Mendelian randomization combined meta-analysis study

Submitted by Frida Mäkelä on Mon, 08/12/2024 - 09:45
  • Read more about Causal relationship analysis between 35 blood/urine metabolites and gastroesophageal reflux disease: A Mendelian randomization combined meta-analysis study

Association between genetically plasma proteins and osteonecrosis: a proteome-wide Mendelian randomization analysis

Submitted by Frida Mäkelä on Fri, 08/09/2024 - 15:12
  • Read more about Association between genetically plasma proteins and osteonecrosis: a proteome-wide Mendelian randomization analysis

Unraveling the causal link: fatty acids and inflammatory bowel disease

Submitted by Frida Mäkelä on Fri, 08/09/2024 - 14:54
  • Read more about Unraveling the causal link: fatty acids and inflammatory bowel disease

Metabolic factors are not the direct mediators of the association between type 2 diabetes and osteoporosis

Submitted by Frida Mäkelä on Fri, 08/09/2024 - 14:36
  • Read more about Metabolic factors are not the direct mediators of the association between type 2 diabetes and osteoporosis

Mapping the genetic landscape of immune-mediated disorders: potential implications for classification and therapeutic strategies

Submitted by Frida Mäkelä on Fri, 08/09/2024 - 11:28
  • Read more about Mapping the genetic landscape of immune-mediated disorders: potential implications for classification and therapeutic strategies

Exploring the relationship between gut microbiota and breast cancer risk in European and East Asian populations using Mendelian randomization

Submitted by Frida Mäkelä on Fri, 08/09/2024 - 10:53
  • Read more about Exploring the relationship between gut microbiota and breast cancer risk in European and East Asian populations using Mendelian randomization

Multisystem health comorbidity networks of metabolic dysfunction-associated steatotic liver disease

Submitted by Frida Mäkelä on Fri, 08/09/2024 - 09:53
  • Read more about Multisystem health comorbidity networks of metabolic dysfunction-associated steatotic liver disease

Lipids, lipid-modified drug target genes, and the risk of male infertility: a Mendelian randomization study

Submitted by Frida Mäkelä on Thu, 08/08/2024 - 16:07
  • Read more about Lipids, lipid-modified drug target genes, and the risk of male infertility: a Mendelian randomization study

Potential Causal Relationship between Faster Walking Pace and Reduced Migraine Risk: A Mendelian Randomization Study

Submitted by Frida Mäkelä on Thu, 08/08/2024 - 15:43
  • Read more about Potential Causal Relationship between Faster Walking Pace and Reduced Migraine Risk: A Mendelian Randomization Study

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 226
  • Page 227
  • Page 228
  • Page 229
  • Current page 230
  • Page 231
  • Page 232
  • Page 233
  • Page 234
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Contact us

Contact person
finngen-info@helsinki.fi
Follow us on Bluesky
@finngen.bsky.social

Lead organisations

The University of Helsinki is the organization responsible for the FinnGen research project. The Finnish consortium partners include all Finnish public biobanks and their background organisations, so the project covers the whole of Finland. All partners are listed on this page.

About the website

Accessibility statement